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Abstract
Background: We investigated the predictive value of atrial electromechanical delay (AEMD) 
for recurrence of atrial fibrillation (AF) at 1-month after cardioversion.
Methods: Seventy-seven patients with persistent AF were evaluated and finally 50 patients 
(12 men, 38 women) were included. All patients underwent transthoracic electrical DC car-
dioversion under amiodarone treatment. AEMD was measured as the time interval from the 
onset of the P wave on electrogram (ECG) to the beginning of late diastolic wave (Am) from the 
ventricular annulus and atrial walls on tissue Doppler imaging, in the apical 4-chamber view 
24 h after cardiversion. P wave maximum-duration (Pmax), P wave minimum-duration  (Pmin) 
and P wave dispersion-duration (Pdis) were calculated on the 12-lead ECG at 24-h postcardio-
version. We followed the heart rate and rhythm by 12-lead ECG at 24-h, 1-week and 1-month.
Results: At 1-month follow-up after cardioversion, 28 (56%) patients were in sinus rhythm 
(SR), whereas 22 (44%) patients reverted to AF. The AEMD durations were longer in AF group 
than SR group (p < 0.001) and were significantly correlated with Pmax and Pdis (p < 0.001  
for both). For AF recurrence; duration of AF, left atrial (LA) diameter, maximum LA volume 
index, mitral A velocity and LA lateral AEMD were significant parameters in univariate-ana-
lysis, however LA lateral AEMD was the only significant parameter in multivariate-analysis 
(OR: 1.46; 95% CI 1.02–2.11; p = 0.03).
Conclusions: Our results suggest that AEMD is associated with an increased risk of recur-
rence of AF within 1-month. These data may have implications for the identification of patients 
who are most likely to experience substantial benefit from cardiversion therapy for AF. (Cardiol J  
2013; 20, 6: 639–647)
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Introduction
Atrial fibrillation (AF), is the most common su-
stained cardiac arrhythmia, affecting approximately 
1–2% of the population and increasing their risk of 
stroke 5 times more than general population [1]. 
AF is also associated with increased mortality, heart 
failure, increased hospitalization, and decreased 
quality of life and exercise capacity [1].
In general, there are 2 treatment strategies 
for AF patients; rate control or rhythm control [1]. 
Even though rate control is acceptable for initial 
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therapy, rhythm control is generally preferred over 
rate control due to offering better symptomatic 
reliefand improved quality of life [1]. Conversion 
of AF to sinus rhythm (SR) prevents electrical and 
structural remodeling in the left atrium (LA) [1]. 
Moreover, restored atrial contraction increases left 
ventricular (LV) filling and contributes to hemo-
dynamic improvement [2]. However, despite the 
widespread use of antiarrhythmic drugs, AF recurs 
in substantial proportion of patients achieving SR 
after cardioversion. For this reason, prediction of 
the recurrence of AF after cardioversion would be 
helpful for tailoring the treatment strategies.
The atrial electromechanic delay (AEMD) is 
the time interval from the onset of P wave on sur-
face electrocardiography (ECG) to the beginning of 
the late diastolic wave on tissue Doppler (Am wave) 
[3, 4]. The delay between the electrical stimulation 
and mechanic contraction results from structural 
changes in the atria. These structural changes also 
lead to a prolongation in P wave duration. P wave 
duration > 120 ms is considered abnormal [5, 6].
We aimed to investigate the predictive value 
of postcardioversion AEMD durations for the re-
currence of AF at 1 month after electrical cardio-
version in patients with persistent AF.
Methods
Patient selection
In this study, we enrolled 70 patients with 
persistent AF presented to cardiology clinic be-
tween September 2010 and June 2011. Patients 
with contraindication to anticoagulation, NYHA 
class III and IV heart failure, prosthetic heart valve 
or severe native valvular heart disease, thrombi 
in the LA, sick sinus syndrome and LA diameter 
> 50 mm were excluded from the study. Fifteen 
patients who met any of the exclusion criteria were 
excluded and 55 patients included to the study. The 
ethical committee of Sevket Yilmaz Training and 
Research Hospital approved the study protocol and 
informed consent was obtained from each patient.
All patients underwent electrical cardiover-
sion. SR could not be restored in 5 cases so they 
were excluded. In the remaining 50 patients, 
cardioversion was successful and those patients 
were followed up.
Study patients
Patients were questioned about demographic 
features and physical examinations were per-
formed. After admission to coronary care unit, 
peripheral venous blood samples were drawn 
for analyzing the complete blood count and main 
biochemical markers. A 12-lead surface ECG was 
obtained before and after cardioversion.
Body mass indices (BMI) were calculated accor-
ding to the following formula: weight [kg]/square 
of the height [m2] and body surface area was cal-
culated as weight (0.425) [kg] × height (0.725) [cm] × 
× 0.007184.
LV mass was calculated using the formula; 
0.8 × 1.04 × [(LV end diastolic diameter + posterior 
wall thickness+ interventricular septum thickness)3 
– (LV end diastolic diameter)3] + 0.6 [7].
Transthoracic echocardiograpy
All patients underwent transthoracic echocar-
diogram (TTE) before cardioversion according to 
the recommendations of the American Society of 
Echocardiography. TTE was performed using Vivid 
7 Pro TTE echocardiography system with 3.5 MHz 
probe on the lateral decubitus position.
LV ejection fraction (LVEF) was calculated 
using the Teichholz formula from the parasternal 
long-axis view using M-mode and LA volume 
was measured using modified biplane area-length 
method [8, 9].
In the apical 4-chamber view, a pulsed wave 
Doppler (PWD) sample volume (3 mm) is placed 
between the mitral leaflet tips and peak E wave 
velocity and E wave deceleration time is measured. 
The interval from the beginning of the R wave on 
electrogram to the beginning of the E wave on PWD 
is measured and defined as TE. Tissue Doppler 
imaging (TDI) was performed at the septal and 
lateral mitral annulus in apical 4-chamber view. 
Gain adjustments were minimized, TDI filter and 
Nyquist limits adjusted to (16–20 cm/s) for getting 
clear tissue signals. Peak systolic (Sm) and early 
diastolic (Em) annular velocities were measured. 
The time between the beginning of the R wave on 
electrogram and beginning of the Em velocity on 
TDI was measured and defined as TEm. The diffe-
rence between TEm and TE intervals was calculated 
by subtracting TE from TEm and defined as TEm–E.
Transesophageal echocardiography
Transesophageal echocardiogram (TEE) was 
performed on all patients with 6 MHz TEE probe 
to exclude atrial thrombus prior to cardioversion. 
Left atrial appendage filling and emptying velocities 
were also recorded with PWD.
Electrical cardioversion
Anticoagulation with heparin was given by 
continuous intravenous infusion (17 U/kg) to all 
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patients before cardioversion and its dose adjusted 
to an activated partial thromboplastin time of 1.5–2 
times normal. All antiarrhythmic drugs including 
digoxin were stopped before cardioversion. Amio-
darone infusion started (5 mg/kg IV loading dose 
infused over 10 min, followed by 10–15 mg/kg/h 
infusion over 24 h) to patients who did not have 
intracardiac thrombus on TTE and TEE studies. 
Patients were sedated with intravenous midazolam 
during the procedure. Transthoracic electrical 
cardioversion was performed with delivery of 
synchronized biphasic DC shocks of 150, 200 and 
270 J in the intensive care unit. Cardioversion 
was considered successful if atrial-P waves were 
unmistakably identified ≥ 1 min after the shock. 
Patients achieving SR received warfarin in a dose 
intended to achieve therapeutic international nor-
malized ratio (INR) of 2.0 to 3.0 after the procedure. 
Oral amiodarone was continued 600 mg/kg for the 
first 2 weeks and then 200 mg/kg the following 
2 weeks. Patients evaluated at 1, 2 and 4 weeks 
after the procedure by physical exam, ECG and 
INR measurements.
Electromechanical time interval  
measurements
The time interval from the onset of P wave 
on surface ECG to the beginning of late diastolic 
wave (Am wave) on TDI, is named as AEMD. 
AEMD interval was obtained on apical 4 chamber 
view from the lateral mitral annulus (mitral late-
ral AEMD), medial mitral annulus (mitral medial 
AEMD), lateral tricuspid annulus (tricuspid late-
ral AEMD), lateral LA wall (LA lateral AEMD), 
interatrial septum (LA medial AEMD) and lateral 
right atrium (RA) wall (RA lateral AEMD) (Fig. 1). 
The difference between mitral lateral AEMD and 
tricuspid lateral AEMD (mitral lateral AEMD – 
tricuspid lateral AEMD) and, LA lateral AEMD 
and RA lateral AEMD (LA lateral AEMD – RA 
lateral AEMD) was defined as inter-atrial electro-
mechanical delay (inter-AEMD). The difference 
between mitral lateral AEMD and mitral medial 
AEMD (mitral lateral AEMD – mitral medial 
AEMD) and, LA lateral AEMD and LA medial 
AEMD (LA lateral AEMD – LA medial AEMD) 
was defined as left intra-electromechanical delay 
(intra-AEMDLEFT). The difference between mitral 
medial AEMD and tricuspid lateral AEMD (mitral 
medial AEMD – tricuspid lateral AEMD) and, LA 
medial AEMD and RA lateral AEMD (LA medial 
AEMD – RA lateral AEMD) was defined as right 
intra-electromechanical delay (intra-AEMDRIGHT).
P-wave duration and P-wave dispersion 
measurement
A 12 lead ECG (filter range, 0.15 to 100 Hz; 
AC filter, 100 Hz; low pass filter, 150 Hz; 25 mm/s; 
10 mm/mV) was obtained from all patients. ECGs 
were transferred to computer and measurements 
were made using AutoCAD 2007 software program. 
The onset of P-wave was defined as the point of the 
first visible upward departure of the trace from the 
bottom of the baseline. The return to the baseline 
of the bottom of the trace in wave was considered to 
be the end of the P-wave. The difference between 
P-wave maximum (Pmax) and P wave minimum (Pmin) 
durations was defined as P-wave dispersion (Pdis).
Data analysis
The data were analyzed using the SPSS 10.0 
statistics package (SPSS Inc, Chicago, Ill, USA). 
Continuous variables are reported as means 
± standard deviation and categorical variables are 
reported as percentages. Student’s t test was used 
for comparison of normal distributed variables and 
Mann-Whitney U test was used for non-normally 
distributed variables. Categorical variables were 
Figure 1. A. Left atrium lateral atrial electromechanical delay (AEMD) duration; B. Right atrium lateral AEMD duration.
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compared by the c2 test or Fisher’s exact test 
as appropriate. Univariate and multivariate logi-
stic regression analyses were used to determine 
significant predictors of AF recurrence following 
cardioversion. Relationship between AEMD du-
rations and Pmax, Pmin and Pdis were calculated 
using Pearson’s correlation tests. The sensitivity 
and specificity of AEMD duration to predict AF 
recurrence was analyzed by receiver operating 
characteristic (ROC) analysis. P values less than 
0.05 were considered significant.
Results
Fifty patients who were successfully cardio-
verted to SR were followed for 1 month. We divided 
study population according to their rhythm at the 
end of 1 month follow-up period. Group 1 consisted 
of 28 patients who were in SR and group 2 consisted 
of 22 patients who reverted to AF at the end of the 
follow-up period. Analysis of baseline characteri-
stics revealed that patients in group 2 had longer 
duration of AF than group 1 (9.3 ± 2 vs. 6.5 ± 2 
months; p < 0.001), the other parameters were 
similar (Table 1).
Precardioversion echocardiographic analysis 
of the study population showed significantly larger 
LA diameter (p < 0.001), LA maximum volume 
(p < 0.001), LA maximum volume index (p < 0.001), 
and LA minimum volume (p = 0.001) in group 2 
than in group 1. Pulmonary artery pressure (PAP) 
was also found to be higher in patients in group 2 
(p = 0.01) (Table 2). The tissue Doppler parame-
ters and TEm–E intervals measured from mitral and 
tricuspid annulus were not significant between 
the groups.
The analysis of echocardiographic data during 
24 h follow-up after cardioversion revealed that LA 
diameter, LA volume index and LA minimum volu-
me were larger in patients in group 2 (p < 0.001 for 
all). The follow-up PAP value was similar between 
two groups. Group 2 had lower mitral A velocities 
(p = 0.005) and higher mitral E/A ratios (p = 0.01) 
as compared to patients in group 1 (Table 3). The 
Table 1. Baseline characteristics of patients in group 1 and group 2. 
Group 1: SR at follow-up
(n = 28)
Group 2: AF at follow-up
(n = 22)
P
Age [years] 61.67 ± 6.89 61.27 ± 7.88 0.84
Female gender 22 (78.6%) 16(72.7%) 0.63
AF duration [months] 6.50 ± 2.44 9.31 ± 1.98 < 0.001
Baseline heart rate [bpm] 112.89 ± 14.28 114.40 ± 20.87 0.76
Body mass index [kg/m2] 32.77 ± 6.99 30.94 ± 5.46 0.31
Body surface area [m2] 1.88 ± 0.17 1.85 ± 0.21 0.59
Blood pressure [mm Hg]
Systolic 129.21 ± 9.11 128.77 ± 9.77 0.87
Diastolic 80.57 ± 7.32 79.22 ± 6.78 0.50
Hemoglobin [g/dL] 13.22 ± 1.28 13.31 ± 1.38 0.81
Creatinine [mg/mL] 0.77 ± 0.28 0.80 ± 0.25 0.72
Cardiversion energy [J] 235.0 ± 35.64 247.72 ± 33.37 0.20
Comorbidities:
Diabetes mellitus 7 (25%) 1 (4.5%) 0.06
Hypertension 21 (75%) 15 (68.2%) 0.59
COPD 4 (14.3%) 3 (13.6%) 0.94
Coronary artery disease 4 (14.3%) 3 (13.6%) 0.94
Smoker 3 (10.7%) 2 (9.1%) 0.84
Medications:
Beta-blocker 19 (67.9%) 17 (77.3%) 0.46
Calcium channel blocker 9 (32.1%) 5 (22.7%) 0.46
ACE inhibitor 12 (42.9%) 7 (31.8%) 0.42
ARB 6 (21.4%) 7 (31.8%) 0.40
Diuretics 3 (10.7%) 4 (18.2%) 0.45
AF — atrial fibrillation; SR — sinus rhythm; COPD — chronic obstructive pulmonary disease; ACE — angiotensin converting enzyme;  
ARB — angiotensin receptor blocker
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Table 2. Comparison of precardioversion echocardiographic data in Group 1 and Group 2.
Group 1: SR Group 2: AF P 
LV end-systolic diameter [mm] 31.64 ± 4.27 31.72 ± 4.67 0.94
LV end-diastolic diameter [mm] 47.85 ± 3.70 47.72 ± 3.04 0.89
LV EF [%] 60.92 ± 5.94 58.31 ± 7.24 0.16
LV mass [g] 188.37 ± 28.49 184.38 ± 20.80 0.58
LA diameter [cm] 40.25 ± 2.84 44.68 ± 2.33 < 0.001
LA maximum volume [mL] 59.75 ± 15.14 78.69 ± 19.04 < 0.001
LA maximum volume index 31.76 ± 8.03 42.75 ± 11.14 < 0.001
LA minimum volume [mL] 29.59 ± 10.22 40.16 ± 11.84 0.001
Pulmonary artery pressure [mm Hg] 34.42 ± 9.06 41.86 ± 10.85 0.01
Mitral E velocity [m/s] 1.02 ± 0.24 1.09 ± 0.30 0.40
Mitral lateral Em velocity [m/s] 0.13 ± 0.05 0.13 ± 0.05 0.83
Mitral lateral E/Em ratio 9.54 ± 6.49 9.04 ± 3.83 0.75
Tricuspid lateral Em velocity [m/s] 0.13 ± 0.04 0.13 ± 0.04 0.75
Mitral lateral interval E–Em 34.12 ± 24.07 35.30 ± 28.32 0.87
Tricuspid lateral interval E–Em 38.55 ± 28.21 36.93 ± 30.99 0.84
LA lateral Sm velocity [m/s] 0.07 ± 0.06 0.06 ± 0.01 0.20
LA lateral Em velocity [m/s] 0.11 ± 0.03 0.11 ± 0.03 0.80
LA medial Sm velocity [m/s] 0.07 ± 0.01 0.06 ± 0.02 0.13
LA medial Em velocity [m/s] 0.10 ± 0.02 0.09 ± 0.03 0.61
RA lateral Sm velocity [m/s] 0.12 ± 0.03 0.11 ± 0.03 0.43
RA lateral Em velocity [m/s] 0.16 ± 0.05 0.17 ± 0.05 0.56
LV — left ventricle; LA — left atrium; RA — right atrium; E — early diastolic wave, A — late diastolic wave; Sm — tissue Doppler systolic 
wave; Em — tissue Doppler early diastolic wave; Am — tissue Doppler late diastolic wave
Table 3. Comparison of echocardiographic findings at 24 hour follow-up after cardioversion between 
group 1 and group 2.
Group 1: SR Group 2: AF P 
Pulmonary artery pressure [mm Hg] 37.10 ± 8.68 39.72 ± 10.37 0.33
Mitral E velocity [m/s] 0.97 ± 0.20 0.97 ± 0.21 0.98
Mitral A velocity [m/s] 0.62 ± 0.20 0.48 ± 0.13 0.005
Mitral E/A ratio 1.70 ± 0.60 2.12 ± 0.57 0.01
Mitral lateral Em velocity [m/s] 0.10 ±0.02 0.10 ± 0.02 0.78
Mitral lateral Am velocity [m/s] 0.07 ± 0.03 0.06 ± 0.03 0.22
Mitral lateral E/Em ratio 10.15 ± 5.27 9.52 ± 3.79 0.64
Tricuspid lateral Em velocity [m/s] 0.11 ± 0.03 0.12 ± 0.04 0.85
Tricuspid lateral Am velocity [m/s] 0.08 ± 0.03 0.08 ± 0.03 0.76
Mitral lateral interval E–Em 35.94 ± 27.18 36.47 ± 27.68 0.94
Tricuspid lateral interval E–Em 46.30 ± 29.90 50.56 ± 36.69 0.65
LA lateral Sm velocity [m/s] 0.07 ± 0.01 0.07 ± 0.02 0.49
LA lateral Em velocity [m/s] 0.10 ± 0.02 0.10 ± 0.02 0.97
LA lateral Am velocity [m/s] 0.07 ± 0.03 0.05 ± 0.02 0.004
LA medial Sm velocity [m/s] 0.07 ± 0.01 0.06 ± 0.02 0.21
LA medial Em velocity [m/s] 0.08 ± 0.02 0.08 ± 0.01 0.43
LA medial Am velocity [m/s] 0.07 ± 0.02 0.05 ± 0.02 0.053
RA lateral Sm velocity [m/s] 0.13 ± 0.03 0.12 ± 0.03 0.49
RA lateral Em velocity [m/s] 0.15 ± 0.04 0.14 ± 0.04 0.53
RA lateral Am velocity [m/s] 0.10 ± 0.04 0.10 ± 0.03 0.93
SR — sinus rhythm; AF — atrial fibrillation; LA — left atrium; RA — right atrium; E — early diastolic wave, A — late diastolic wave;  
Sm — tissue Doppler systolic wave; Em — tissue Doppler early diastolic wave; Am — tissue Doppler late diastolic wave
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TEm-E intervals measured at mitral and tricuspid 
annulus were not significant between the groups. 
LA lateral Sm and Em velocities, LA medial Sm and 
Em velocities and, RA lateral Sm and Em velocities 
were similar between groups, while LA lateral Am 
velocities were lower in group 2 (p = 0.004). LA 
medial and RA lateral velocities were also similar 
between two groups (Table 3).
Mitral lateral AEMD, mitral medial AEMD, 
tricuspid lateral AEMD, LA lateral AEMD, LA 
medial AEMD and RA lateral AEMD durations 
were significantly higher in group 2 compared with 
group 1 (p < 0.001 for all) (Table 4). However, 
inter-AEMD, intra-AEMDLEFT and intra-AEMDRIGHT 
durations were similar in both groups.
Bivariate correlation analysis between LA 
diameter, LA maximum volume and LA lateral 
AEMD duration showed that both LA diameter and 
LA maximum volume are significantly correlated 
with LA lateral AEMD 24 h after cardioversion 
(LA diameter: r = 0.54, p < 0.001; LA maximum 
volume: r = 0.51, p < 0.001).    
Analysis of P-wave durations showed pro-
longed Pmax (85.55 ± 5.43 vs. 110.78 ± 8.38) and 
Pdis (28.79 ± 5.55 vs. 53.36 ± 8.31) in group 2 
(p < 0.001 for both). Bivariate correlation analysis 
Table 4. Comparison of atrial electromechanical parameters.
Group 1: SR Group 2: AF P 
Ventricular annular measurements:
Mitral lateral AEMD  72.71 ± 5.62 82.00 ± 5.61 < 0.001
Mitral medial AEMD 63.36 ± 4.84 74.34 ± 7.02 < 0.001
Tricuspid lateral AEMD 58.20 ± 4.41 68.06 ± 7.76 < 0.001
Inter-AEMD 14.51 ± 6.50 13.93 ± 8.76 0.79
Intra-AEMDLEFT 9.34 ± 4.92 7.66 ± 6.31 0.29
Intra-AEMDRIGHT 5.16 ± 5.90 6.27 ± 7.95 0.57
Atrial walls measurements:
LA lateral AEMD 70.23 ± 6.66 83.43 ± 8.82 < 0.001
LA medial AEMD 61.38 ± 4.04 70.45 ± 10.13 < 0.001
RA lateral AEMD 55.27 ± 4.31 65.54 ± 9.27 < 0.001
Inter-AEMD 14.96 ± 6.47 17.89 ± 11.33 0.25
Intra-AEMDLEFT 8.85 ± 5.94 12.98 ± 8.72 0.053
Intra-AEMDRIGHT 6.10 ± 3.11 4.91 ± 6.73 0.41
SR — sinus rhythm; AF — atrial fibrillation; AEMD — atrial electromechanical delay; LA — left atrium; RA — right atrium
Table 5. Correlation analysis between P-wave measurements and atrial electromechanical delay para-
meters.
Parameter Duration P maximum P minimum P-wave dispersion
R P R P R P 
Mitral lateral AEMD 76.80 ± 7.25 0.54 < 0.001 0.01 0.89 0.55 < 0.001
Mitral medial AEMD 68.19 ± 8.02 0.59 < 0.001 –0.18 0.19 0.67 < 0.001
Tricuspid lateral AEMD 62.54 ± 7.81 0.61 < 0.001 –0.04 0.78 0.64 < 0.001
Inter-AEMD 14.26 ± 7.50 –0.11 0.43 0.06 0.67 –0.13 0.34
Intra-AEMDLEFT 8.60 ± 5.58 –0.14 0.32 0.21 0.09 –0.25 0.07
Intra-AEMDRIGHT 5.65 ± 6.83 –0.08 0.95 –0.17 0.22 0.06 0.68
LA lateral AEMD 76.04 ± 10.08 0.62 < 0.001 0.08 0.55 0.60 < 0.001
LA medial AEMD 65.37 ± 8.58 0.46 0.001 –0.09 0.51 0.51 < 0.001
RA lateral AEMD 59.79 ± 8.58 0.59 < 0.001 0.03 0.79 0.59 < 0.001
Inter-AEMD 16.25 ± 8.95 0.12 0.37 0.06 0.67 0.10 0.45
Intra-AEMDLEFT 10.67 ± 7.50 0.30 0.03 0.22 0.11 0.21 0.12
Intra-AEMDRIGHT 5.58 ± 5.01 –0.21 0.12 –0.22 0.11 –0.13 0.34
AEMD — atrial electromechanical delay; LA — left atrium; RA — right atrium
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between P-wave duration and AEMD durations sho-
wed that both Pmax and Pdis are significantly correlated 
with mitral lateral AEMD, mitral medial AEMD, tri-
cuspid lateral AEMD, LA lateral AEMD, LA medial 
AEMD and RA lateral AEMD durations (Table 5).
A ROC analysis was then performed to assess 
the predictive power of the AEMD durations for AF 
recurrence at 1 month postcardioversion. The area 
under the curve was calculated to be 0.89, 0.89, 
0.89, 0.94, 0.88 and 0.89 for mitral lateral AEMD, 
mitral medial AEMD, tricuspid lateral AEMD, LA 
lateral AEMD, LA medial AEMD and RA lateral 
AEMD, respectively, indicating that all these 
parameters are associated with AF recurrence 
following electrical cardioversion (Fig. 2).
Using a univariate and multivariate regression 
models, the patients’s age, AF duration, energy 
delivered during cardioversion, LA diameter, mitral 
A velocity, PAP, LA maximum volume index, LA 
lateral Am velocity and LA lateral AEMD dura-
tion, which was found to have highest sensitivity 
and specificity to predict AF recurrence in ROC 
analysis, were included as predictor variables for 
arrhythmia recurrence at 1 month follow-up after 
successful cardioversion. In univariate analysis, 
AF duration, LA diameter, LA maximum volume 
index, mitral A velocity, LA lateral Am velocity 
and LA lateral AEMD duration were found to be 
significant predictor of AF recurrence. In multi-
variate analysis, only LA lateral AEMD duration 
was a significant predictor of AF recurrence with 
an odds ratio of 1.46 (p = 0.03) (Table 6).
Discussion
In our study, we found that AEMD durations 
predict recurrence of AF at 1 month following elec-
trical cardioversion in patients with persistent AF. 
Table 6. Univariate and multivariate logistic regression analysis of predictors of recurrence.
Univariate analysis Multivariate analysis
Odds ratio (95% CI) P Odds ratio (95% CI) P 
Age 0.99 (0.91–1.07) 0.84
AF duration 1.88 (1.28–2.76) 0.001 1.49 (0.80–2.77) 0.20
Cardioversion energy 1.01 (0.99–1.02) 0.19
LA diameter 1.96 (1.35–2.86) 0.004 1.60 (0.90–2.82) 0.10
LA maximum volume index 1.13 (1.04–1.23) 0.003 1.02 (0.81–1.28) 0.85
Mitral A velocity 0.03 (0.005–2.65) 0.01 0.01 (0.002–5.62) 0.50
Pulmonary artery pressure 1.03 (0.97–1.09) 0.33
LA lateral Am velocity 0.02 (0.005–10.08) 0.009 0.01 (0.008–12.66) 0.39
LA lateral AEMD duration 1.58 (1.18–2.12) 0.002 1.46 (1.02–2.11) 0.03
CI — confidence interval; AF — atrial fibrillation; AEMD — atrial electromechanical delay; LA — left atrium
Figure 2. Atrial electromechanical delay (AEMD): atrial 
electromechanical delay; CI — confidence interval; 
LA — left atrium; RA — right atrium; AUC — area under 
the curve.
In addition, we demonstrated that P-wave disper-
sion and P-wave maximum duration are prolonged 
in recurrent patients and there is a significant 
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correlation between those two parameters and 
AEMD durations.
Identification of predictors for AF recurrence 
might play a key role in selection of treatment 
strategies. Several studies have been conducted 
to determine the predictors of AF recurrence, 
however none of the parameters have achieved to 
predict with 100%. That is why new parameters 
are still studied for predicting the recurrence of AF.
Long durations of AF result in electrical and 
structural changes in the LA, the so-called atrial 
remodeling. This atrial remodeling is characteri-
zed by atrial dilatation and deterioration of atrial 
conduction. Tieleman et al. [10] have demonstrated 
that persistent AF changes atrial refractory period 
and leads recurrence of AF by this mechanism. 
Total atrial conduction time (TACT) has been 
proposed as a marker of atrial remodeling and 
represents the time between the onset of atrial 
depolarization from the sinus node to the farthest 
point of atria [3, 4, 10]. This interval increases in 
patients with persistent AF due to increased atrial 
diameter and intra-atrial conduction delay [10, 11]. 
The TACT resulting from beat-to-beat variability 
is also associated with increased AF recurrence 
[10, 11]. The delay in TACT can be measured on 
12-lead surface ECG by maximum P-wave duration, 
whereas the beat-to-beat varying atrial conduction 
time is measured by P-wave dispersion.
The delays in inter-atrial conduction time and 
intra-atrial conduction time and, prolonged Pdis 
have been shown to be related to AF recurrence 
[12, 13]. Ermis et al. [14] reported increased risk 
of persitent AF development in pre-hypertensive 
patients who had prolonged P-wave duration. In 
the present study, patients who reverted back 
to AF after cardioversion had longer Pmax and Pdis 
than patients who stayed in SR. However, incre-
ased LA diameters and the diseases in the atrial 
conduction pathways make the evaluation of these 
parameters difficult and can cause errors in the 
measured patterns. High-resolution ECG records 
and electrophysiologic studies could get a more 
accurate P wave duration measurements, however 
this not practical.
In our study, the AEMD durations obtained 
from the atrial walls and ventricular annulus pre-
dicted the recurrence of AF at 1 month. AEMD 
duration is the sum of impulse propagation from 
sinus node to the atria and atrial electromechanical 
coupling duration. The histopathological changes 
in the atria are the most significant determinants 
of AEMD duration. Atrial fibrosis, myocyte atrophy 
and scattered fibrotic foci in the normal atrial tissue 
lead a non-homogenious conduction of impulses in 
the atriums. The prolonged Pmax and Pdis durations 
resulting from non-homogenious atrial conduction 
are significantly correlated with AEMD durations. 
AEMD duration is also well correlated with the 
degree of histopathological changes [11]. LA lateral 
AEMD duration significantly correlated with LA 
diameter and LA maximum volume. These data 
explain the importance of AEMD durations, which 
is an indicator of pathological changes in the atrium, 
for predicting AF recurrence.
The time of AEMD measurement could also 
be important to predict AF recurrence. Atrial 
stunning is prominent in the first hours following 
cardioversion and measurements within this period 
can have a significant impact on AEMD durations. 
To exclude this limitation we performed the mea-
surements at 24 h postcardioversion.
We did not find a relation between inter-AEMD 
duration and AF recurrence. This might be attri-
buted to the fact that our patients were relatievely 
young (mean age; 61 years) and had mildly dilated 
LA (mean diameter; 42.5 mm). Age is an important 
factor affecting atrial histopathological changes 
and conduction times. Atrial conduction times are 
prolonged in patients with older age and increased 
LA enlargement.
AF duration before cardioversion is an im-
portant clinical parameter for prediction of AF 
recurrence [10, 13]. In our study, patients with AF 
recurrence had longer duration of AF than patients 
who did not recur. However, duration of AF can not 
be accurately assessed in some patients and this 
limits the implication of this parameter.
LA diamater and volume are among the pre-
dictors for recurrence of AF [14–16]. Both pre-
cardioversion and postcardioversion LA dimaters 
and LA volumes were found to be significantly 
increased in patients with AF recurrence. These 
results support that LA dimater and LA volume are 
useful parameters for prediction of AF. However, 
beat-to-beat variations in atrial contractile function 
during AF can cause errors in the measurements 
of these parameters. Particularly, the beat-to-beat 
variability will be very marked in in patients with 
significant mitral regurgitation. These factors limit 
the use of LA diameter and volume as predictor of 
recurrence.
Our study also demonstrated increased LA 
lateral Sm, Am and mitral A velocities in patients 
staying in SR at 1 month as compared to patients 
with AF recurrence. As the duration of AF and 
stress in the LA increases, the degree of atrial 
remodeling enhances and this result in reduce in 
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atrial contraction velocities [17]. Several previous 
studies are consistent with our results [13, 15]. 
However, measurements of LA systolic and late 
diastolic velocities in the early periods following 
cardioversion may show lower values than the real 
values because of atrial stunning. Therefore, these 
parameters have limited value in the prediction of 
AF recurrence.
Duration of AF, LA diameter, LA maximum 
volume index, mitral A velocity, LA lateral Am 
velocity and LA lateral AEMD duration were found 
to be significant predictors of AF recurrence at 
1 month follow-up in univariate analysis, whereas LA 
lateral AEMD duration was the only significant pa-
rameter in multivariate analysis. These data show 
that AEMD durations are independent predictors of 
AF recurrence. The results of study conducted by 
Park et al. [18] support our findings. Park et al. [18] 
showed that AEMD duration significantly longer in 
patients with AF recurrence than in patients with 
SR 6 months after cardioversion and normal control 
population. Also they showed that AEMD duration 
correlated with LA volumes as our study results.
Clinical implication
The atrial mechanical delay duration is pro-
longed in patients with AF recurrence. Prolonged 
AEMD durations predict short-term AF recurrence 
(at 1 month), hence they could be used for patient 
follow-up after cardioversion. These early results 
also suggest that more aggressive treatment of 
patients with prolonged AEMD durations might 
prevent recurrence of AF after cardioversion.
Limitations of the study
The first limitation of our study was the re-
latively small number of patients. The limited 
patients number in this study may not represent 
the whole population. Second limitation was that 
patients were not randomized according to the 
antiarrhythmic treatment. However, the number 
and group of antiarrhythmic drugs were not diffe-
rent between two groups and all patients received 
amiodarone after cardioversion. Third limitation 
was the short duration of follow-up. One month 
follow-up results might not be an indicator for 
AEMD duration to predict AF recurrence for long-
-term. However, the results of this pilot study can 
be a guide to further studies.
Conclusions
Postcardioversion AEMD durations predict 
recurrence of AF at 1 month follow-up in patients 
with persistent AF. If rhythm control is desired, 
more aggressive treatment approaches might be 
needed in patients with marked AEMD prolonga-
tion. The results of this pilot study showing AEMD 
durations as predictor of AF recurrence need to be 
confirmed with larger group of patients and long-
-term follow-up studies.
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